Literature DB >> 21824341

A national epidemic of campylobacteriosis in Iceland, lessons learned.

J Tustin1, K Laberge, P Michel, J Reiersen, S Dađadóttir, H Briem, H Harđardóttir, K Kristinsson, E Gunnarsson, V Friđriksdóttir, F Georgsson.   

Abstract

Epidemics often result in organizational, policy and technical changes within a country. In 1999, an epidemic of campylobacteriosis was reported in Iceland. The recent availability of fresh poultry products in the marketplace was suggested as the source of infection. This paper reports on the context of the epidemic, reviews interventions implemented to prevent campylobacteriosis, and discusses lessons learned. A retrospective study of interventions implemented in Iceland from June 1995 to December 2007 was conducted by interviewing key informants and reviewing Iceland's literature. Cumulative incidence rates of domestic campylobacteriosis by year and average incidence rates per epidemic period were calculated. Interventions included on-farm surveillance of Campylobacter, producer education, enhanced biosecurity measures, changes in poultry processing, a leak-proof packaging policy, a freezing policy for products from Campylobacter-positive poultry flocks, consumer education, and the creation of a legislated inter-organizational response committee. These interventions appear to have collectively contributed to a decrease in campylobacteriosis' incidence rate near pre-epidemic baseline levels. Expert consultations revealed that the implementation of a Campylobacter surveillance program in poultry and the freezing policy were critical to controlling the disease in the Icelandic population. It was also recognized that new multidisciplinary collaborations among public health, veterinary, and food safety authorities and a sustained co-operation from the poultry industry were integral factors to the mitigation of the epidemic. Iceland's response to the campylobacteriosis epidemic is a lesson learned of inter-disciplinary and inter-organizational precautionary public health action in the face of a complex public health issue.
© 2011 Blackwell Verlag GmbH.

Entities:  

Mesh:

Year:  2011        PMID: 21824341     DOI: 10.1111/j.1863-2378.2010.01387.x

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  5 in total

1.  A combined case-control and molecular source attribution study of human Campylobacter infections in Germany, 2011-2014.

Authors:  Bettina M Rosner; Anika Schielke; Xavier Didelot; Friederike Kops; Janina Breidenbach; Niklas Willrich; Greta Gölz; Thomas Alter; Kerstin Stingl; Christine Josenhans; Sebastian Suerbaum; Klaus Stark
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

2.  Operationalising factors that explain the emergence of infectious diseases: a case study of the human campylobacteriosis epidemic.

Authors:  Norval J C Strachan; Ovidiu Rotariu; Marion MacRae; Samuel K Sheppard; Alison Smith-Palmer; John Cowden; Martin C J Maiden; Ken J Forbes
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

3.  Consumer acceptability of interventions to reduce Campylobacter in the poultry food chain.

Authors:  L A MacRitchie; C J Hunter; N J C Strachan
Journal:  Food Control       Date:  2014-01       Impact factor: 5.548

4.  A tradition and an epidemic: determinants of the campylobacteriosis winter peak in Switzerland.

Authors:  Philipp Justus Bless; Claudia Schmutz; Kathrin Suter; Marianne Jost; Jan Hattendorf; Mirjam Mäusezahl-Feuz; Daniel Mäusezahl
Journal:  Eur J Epidemiol       Date:  2014-07-03       Impact factor: 8.082

Review 5.  Critical Orientation in the Jungle of Currently Available Methods and Types of Data for Source Attribution of Foodborne Diseases.

Authors:  Lapo Mughini-Gras; Pauline Kooh; Philippe Fravalo; Jean-Christophe Augustin; Laurent Guillier; Julie David; Anne Thébault; Frederic Carlin; Alexandre Leclercq; Nathalie Jourdan-Da-Silva; Nicole Pavio; Isabelle Villena; Moez Sanaa; Laurence Watier
Journal:  Front Microbiol       Date:  2019-11-12       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.